Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia
Open accessThe DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index; 31 of the 126 sources its claims cite were checked for support.
Abstract
Human gut microbiota is able to influence the host physiology by regulating multiple processes, including nutrient absorption, inflammation, oxidative stress, immune function, and anabolic balance. Aging is associated with reduced microbiota biodiversity, increased inter-individual variability, and over-representation of pathobionts, and these phenomena may have great relevance for skeletal muscle mass and function. For this reason, the presence of a gut-muscle axis regulating the onset and progression of age-related physical frailty and sarcopenia has been recently hypothesized. In this narrative review, we summarize the studies supporting a possible association between gut microbiota-related parameters with measures of muscle mass, muscle function, and physical performance in animal models and humans. Reduced muscle mass has been associated with distinct microbiota composition and reduced fermentative capacity in mice, and the administration of probiotics or butyrate to mouse models of muscle wasting has been associated with improved muscle mass. However, no studies have targeted the human microbiome associated with sarcopenia. Limited evidence from human studies shows an association between microbiota composition, involving key taxa such as Faecalibacterium and Bifidobacterium, and grip strength. Similarly, few studies conducted on patients with parkinsonism showed a trend towards a different microbiota composition in those with reduced gait speed. No studies have assessed the association of fecal microbiota with other measures of physical performance. However, several studies, mainly with a cross-sectional design, suggest an association between microbiota composition and frailty, mostly assessed according to the deficit accumulation model. Namely, frailty was associated with reduced microbiota biodiversity, and lower representation of butyrate-producing bacteria. Therefore, we conclude that the causal link between microbiota and physical fitness is still uncertain due to the lack of targeted studies and the influence of a large number of covariates, including diet, exercise, multimorbidity, and polypharmacy, on both microbiota composition and physical function in older age. However, the relationship between gut microbiota and physical function remains a very promising area of research for the future.
Overview
CoChat Summary
TL;DR
This narrative review summarizes animal and human evidence for a gut-muscle axis linking gut microbiota to muscle mass, muscle function, and physical frailty/sarcopenia in aging. It concludes that the association is biologically plausible and supported by limited studies, but causality remains uncertain because targeted human studies are lacking and many covariates confound both microbiota and physical function.
Key findings
- Animal studies support a possible gut-muscle axis: reduced muscle mass has been associated with distinct microbiota composition and reduced fermentative capacity in mice, and probiotics or butyrate administration improved muscle mass in mouse models of muscle wasting.
- No studies have targeted the human microbiome specifically associated with sarcopenia; limited human evidence shows associations between microbiota composition, involving taxa such as *Faecalibacterium* and *Bifidobacterium*, and grip strength.
- In a randomized controlled trial of 60 nursing home residents, a prebiotic containing inulin and fructooligosaccharides improved hand-grip strength after 13 weeks (12.4 ± 3.2 vs. 10.2 ± 4.1 kg, p = 0.04), although fecal microbiota composition was not assessed.
- Frailty, mostly assessed by the deficit accumulation model/Rockwood Frailty Index, was associated with reduced microbiota biodiversity and lower representation of butyrate-producing bacteria; one trial in 50 nursing home residents found a mild but statistically significant reduction in a 62-item frailty index after prebiotic administration.
Methods
- Narrative review; papers searched on PubMed as of 1 June 2019 using terms including microbiota AND “muscle function,” sarcopenia, “muscle mass,” “muscle wasting,” frailty, “gait speed,” “muscle strength,” “grip strength,” and “physical performance.”
- A systematic review approach was not possible due to the low number of human studies and heterogeneity of settings, participants, and outcome measures; human studies relevant to the primary aim were discussed, with animal studies included for possible pathophysiological mechanisms.
- The review summarizes studies on microbiota-related parameters with measures of muscle mass, muscle function, and physical performance, including grip strength, gait speed, timed up-and-go, and frailty indices.
Limitations
- The paper states that the causal link between microbiota and physical fitness remains uncertain due to lack of targeted studies and the influence of many covariates, including diet, exercise, multimorbidity, and polypharmacy, on both microbiota composition and physical function in older age.
- The paper states that most human studies are cross-sectional, so causality cannot be inferred; no human studies have directly assessed an association between gut microbiota composition and skeletal muscle mass in age-related sarcopenia.
- The paper states that frailty studies mostly used the Rockwood Frailty Index or Clinical Frailty Scale, which do not directly assess muscle function and performance; gait speed studies were not focused on older people with sarcopenia or physical frailty and did not follow geriatric assessment recommendations.
- Evident from the text: this is a narrative rather than systematic review, with a search limited to 1 June 2019, and much of the mechanistic evidence comes from animal models whose translation to humans is uncertain.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
16 Valid · 6 Not valid · 66 Not checked · 21 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Healthy, active older subjects, including centenarians, show a microbiota composition resembling that of adult subjects, with limited features of dysbiosis [45,46].”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 1. Introduction > 1.2. Gut Microbiota: A Novel Player in Sarcopenia and Physical Frailty?
What the sources say
- Partly supportedcites [45] Kim S. Jazwinski S.M. The gut microbiota and healthy aging: A mini-review Gerontology 2018 64 513 520 10.1159/000490615 30025401 PMC6191326 sourceExperimental — accuracy not yet measured
In “The human gut microbiota” (page unavailable), the review says young adults and centenarians share a core microbiota, supporting a limited resemblance. But “Changes in the gut microbiota associated with longevity or healthy aging” (page unavailable) reports age-related compositional differences; it does not establish that healthy, active older people have an adult-like overall composition or only limited dysbiosis. (LLM, conf=0.84)
- Disputedcites [46] Biagi E. Nylund L. Candela M. Ostan R. Bucci L. Pini E. Nikkïla J. Monti D. Satokari R. Franceschi C. Through ageing, and beyond: Gut microbiota and inflammatory status in seniors and centenarians PLoS ONE 2010 5 e10667 10.1371/annotation/df45912f-d15c-44ab-8312-e7ec0607604d 20498852 PMC2871786 sourceExperimental — accuracy not yet measured
The Discussion (page not supplied) says young and elderly adults have comparable gut microbiota, but explicitly says centenarians differ significantly from the adult-like pattern and have lower diversity. The fecal-profile results likewise report significantly different microbiota profiles in centenarians. Thus the source contradicts the claim’s inclusion of centenarians. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Namely, the circulating levels of microbiota-derived indoxyl sulfate are positively associated with the expression of myostatin and atrogin-1 [29], representing two of the main negative regulators of skeletal muscle mass [30].”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 1. Introduction > 1.2. Gut Microbiota: A Novel Player in Sarcopenia and Physical Frailty?
What the sources say
- Partly supportedcites [29] Enoki Y. Watanabe H. Arake R. Sugimoto R. Imafuku T. Tominaga Y. Ishima Y. Kotani S. Nakajima M. Tanaka M. Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1 Sci. Rep. 2016 6 32084 10.1038/srep32084 27549031 PMC4994088 sourceExperimental — accuracy not yet measured
The Results (page not available in our copy) show that administering indoxyl sulfate increased myostatin and atrogin-1 expression in the skeletal muscle of half-nephrectomized mice. They do not establish a positive association between circulating indoxyl sulfate levels and expression: plasma trough levels only tended to rise in treated mice (p = 0.15). The cited study used administered indoxyl sulfate rather than testing a microbiota-derived exposure. (LLM, conf=0.86)
- Supportedcites [30] Sakuma K. Yamaguchi A. Sarcopenia and cachexia: Tha adaptations of negative regulators of skeletal muscle mass J. Cachexia Sarcopenia Muscle 2012 3 77 94 10.1007/s13539-011-0052-4 22476916 PMC3374017 source
The citation to this paper is attached to the description of myostatin and atrogin-1 as negative regulators of skeletal muscle mass, not to the preceding indoxyl-sulfate association, which cites [29]. The Sarcopenia section explicitly calls Atrogin-1 and myostatin common negative regulators; it does not need to establish the indoxyl-sulfate association to support the part attributed to [30]. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“the administration of probiotics or butyrate to mouse models of muscle wasting has been associated with improved muscle mass”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > Abstract
What the sources say
- Partly supportedcites [66] Varian B.J. Goureshetti S. Poutahidis T. Lakritz J.R. Levkovich T. Kwok C. Teliousis K. Ibrahim Y.M. Mirabal S. Erdman S.E. Beneficial bacteria inhibit cachexia Oncotarget 2016 7 11803 11816 10.18632/oncotarget.7730 26933816 PMC4914249 sourceExperimental — accuracy not yet measured
The Results (Figure 1; page unavailable) report improved muscle measures in a mouse model of cancer-associated cachexia after treatment with the probiotic L. reuteri. The Experimental design section describes L. reuteri administration, but our copy provides no evidence that butyrate was administered or improved muscle mass (searched: butyrate). (LLM, conf=0.88)
- Partly supportedcites [67] Bindels L.B. Beck R. Schackman O. Martin J.C. De Backer F. Sohet F.M. Dewulf E.M. Pachikian B.D. Neyrinck A.M. Thissen J.P. Restoring specific Lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model PLoS ONE 2012 7 e37971 10.1371/journal.pone.0037971 22761662 PMC3384645 sourceExperimental — accuracy not yet measured
The Results report that two Lactobacillus strains increased tibialis muscle weight by 8% in leukemic mice, although gastrocnemius weight did not change significantly. This supports the probiotic part of the claim for specific strains and one muscle; our copy does not report butyrate administration or its effect on muscle mass (searched: butyrate). (LLM, conf=0.88)
- Partly supportedcites [71] Walsh M.E. Bhattacharya A. Staranatarajan K. Qaisar R. Sloane L. Rahman M.M. Kinter M. Van Remmen H. The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging Aging Cell 2015 14 957 970 10.1111/acel.12387 26290460 PMC4693467 sourceExperimental — accuracy not yet measured
The section “Butyrate prevents hindlimb muscle loss during aging” reports that aged mice given butyrate lost less hindlimb muscle mass than controls. The Experimental procedures describe a butyrate-containing diet, not probiotic administration; our copy does not support the probiotic part of the claim. (LLM, conf=0.89)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Finally, transplantation of the intestinal microbiota from pigs to lean germ-free mice resulted in significant changes of muscle fibers structure, resembling to that typical of pigs [51].”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 2. Gut Microbiota and Muscle Mass > 2.1. The Microbiota as Transducer of Nutrient Signals
What the sources say
- Partly supportedcites [51] Yan H. Diao H. Xiao Y. Li W. Yu B. He J. Yu J. Zheng P. Mao X. Luo Y. Gut microbiota can transfer fiber characteristics and lipid metabolic profiles of skeletal muscle from pigs to germ-free mice Sci. Rep. 2016 6 31786 10.1038/srep31786 27545196 PMC4992887 sourceExperimental — accuracy not yet measured
The Results section ('The two groups of mouse recipients developed different body compositions, fiber characteristics and fiber type distributions') confirms that GF BALB/C mice colonized with porcine fecal suspension mirrored their pig donors in fiber type: MYH7 (slow type I) was higher and MYH4 (fast IIb) lower in RM versus YM at p < 0.05, and the Discussion states RP/RM exhibited higher type I and lower type IIb fibers. However, the morphological 'structure' measures the claim names — fiber diameter and cross-sectional area of the gastrocnemius — were only non-significant trends in both donors (p = 0.0994) and recipients (p = 0.0832), so 'significant changes of muscle fiber structure' overstates the source. Our copy also does not describe the germ-free recipients as 'lean'; the lean/obese contrast applies to the Yorkshire vs Rongchang pig donors. (LLM, conf=0.75)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The effects of protein intake on the gut microbiota composition, and the consequences for muscle mass deposition, may depend on protein quality and microbiota metabotype [54], so that the pro-anabolic response to protein intake, mediated by the microbiota, may be different on an individual basis.”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 2. Gut Microbiota and Muscle Mass > 2.1. The Microbiota as Transducer of Nutrient Signals
What the sources say
- Partly supportedcites [54] Liao Y. Peng Z. Chen L. Zhang Y. Cheng Q. Nüssler A.K. Bao W. Liu L. Yang W. Prospective views for whey protein and/or resistance training against age-related sarcopenia Aging Dis. 2019 10 158 174 10.14336/AD.2018.0325 30705776 PMC6345331 sourceExperimental — accuracy not yet measured
The section ‘Gut microbiota: a key factor for whey protein and/or resistance training against age-related sarcopenia?’ says protein quality affects gut microbiota in mice and discusses ways microbiota may influence skeletal muscle. It does not establish that the consequences for muscle mass deposition depend on protein quality or microbiota metabotype; the copy provides no page number for these passages. (LLM, conf=0.84)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
63 more claims · 7 with their cited sources checked
Create a free account to see all 109 claims and to verify the 95 references still open.
- It may state two separate claims as one. 37
- Probably not a substantial claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Anabolic resistance is associated with reduced gene expression in proteins involved in MPS, impaired protein absorption and digestion, loss of skeletal-muscle stem cells, and decreased amino-acid transportation in the skeletal muscle [19,137,138].”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [19]
Experimental — accuracy not yet measuredIn the citing paper
“Gut microbiota dysbiosis is linked to age-related systemic inflammation, leading to impaired muscle function and increased proinflammatory cytokines, which are associated with higher risk of obesity [19].”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 3. Gut Microbiota and Parameters of Muscle Function > 3.3. Gut Microbiota and Other Parameters of Physical Performance
“Similar intervention studies were performed in healthy adults, evaluating physical performance by measuring endurance capacity, which is not part of standard geriatric assessment [88,109].”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 3. Gut Microbiota and Parameters of Muscle Function > 3.1. Gut Microbiota and Muscle Strength
“In another experimental study, the administration of resveratrol, a polyphenol compound able to promote skeletal and cardiac muscle cell biogenesis and remodeling, to mouse models of heart failure resulted in significant changes in intestinal microbiota composition, but no improvement in muscle strength [88].”
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Guralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792
Clegg, A., Young, J., Iliffe, S., Rikkert, M. O., & Rockwood, K. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62167-9 · Cited by 9,503 · cited 1×
“This condition frequently overlaps with physical frailty [3], representing the reduction of the capacity to maintain fitness, physical performance and sense of well-being over time and particularly after stressors such as acute illnesses [4].”
BackgroundThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803 · cited 1×
“fractures, disability and mortality [1,2].”
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690
Gut microbiota composition correlates with diet and health in the elderly
Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., Lakshminarayanan, B., O’Sullivan, O., et al. (2012) · Nature · doi:10.1038/nature11319 · Cited by 3,314
Guralnik, J. M., Ferrucci, L., Pieper, C. F., Leveille, S. G., Markides, K. S., Ostir, G. V., Studenski, S., Berkman, L. F., & Wallace, R. B. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.4.m221 · Cited by 2,898
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Rivière, A., Selak, M., Lantin, D., Leroy, F., & De Vuyst, L. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00979 · Cited by 1,726
Neurotransmitter modulation by the gut microbiota
Strandwitz, P. (2018) · Brain Research · doi:10.1016/j.brainres.2018.03.015 · Cited by 1,527
Through Ageing, and Beyond: Gut Microbiota and Inflammatory Status in Seniors and Centenarians
Biagi, E., Nylund, L., Candela, M., Ostan, R., Bucci, L., Pini, E., Nikkïla, J., Monti, D., Satokari, R., Franceschi, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010667 · Cited by 1,483
Branched-chain amino acids in metabolic signalling and insulin resistance
Lynch, C. J., & Adams, S. H. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.171 · Cited by 1,461
Thevaranjan, N., Puchta, A., Schulz, C., Naidoo, A., Szamosi, J. C., Verschoor, C. P., Loukov, D., Schenck, L. P., Jury, J., Foley, K. P., et al. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.03.002 · Cited by 1,322 · cited 1×
“This phenomenon results into increased systemic absorption of bacterial products, including lipopolysaccharide, activating the inflammatory response and ultimately resulting into increased circulating levels of pro-inflammatory cytokines, such as interleukin-6 and tumor necrosis factor-α [27].”
BackgroundFrailty measurement in research and clinical practice: A review
Dent, E., Kowal, P., & Hoogendijk, E. O. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.03.007 · Cited by 1,292
Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis
Beaudart, C., Zaaria, M., Pasleau, F., Reginster, J.-Y., & Bruyère, O. (2017) · PLOS ONE · doi:10.1371/journal.pone.0169548 · Cited by 1,272 · cited 1×
“fractures, disability and mortality [1,2].”
Grip Strength across the Life Course: Normative Data from Twelve British Studies
Dodds, R. M., Syddall, H. E., Cooper, R., Benzeval, M., Deary, I. J., Dennison, E. M., Der, G., Gale, C. R., Inskip, H. M., Jagger, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113637 · Cited by 1,221
O’Toole, P. W., & Jeffery, I. B. (2015) · Science · doi:10.1126/science.aac8469 · Cited by 1,202
Walking Speed: The Functional Vital Sign
Middleton, A., Fritz, S. L., & Lusardi, M. (2015) · Journal of Aging and Physical Activity · doi:10.1123/japa.2013-0236 · Cited by 1,186
Fried, L. P. (2001) · Journals of Gerontology Series A-biological Sciences and Medical Sciences · Cited by 1,103
Frailty and the Prediction of Negative Health Outcomes: A Meta-Analysis
Vermeiren, S., Vella-Azzopardi, R., Beckwée, D., Habbig, A.-K., Scafoglieri, A., Jansen, B., Bautmans, I., Bautmans, I., Verté, D., Beyer, I., et al. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.09.010 · Cited by 1,022
The Human Gut Microbiome: From Association to Modulation
Schmidt, T. S. B., Raes, J., & Bork, P. (2018) · Cell · doi:10.1016/j.cell.2018.02.044 · Cited by 845
Exercise alters gut microbiota composition and function in lean and obese humans
ALLEN, J. M., MAILING, L. J., NIEMIRO, G. M., MOORE, R., COOK, M. D., WHITE, B. A., HOLSCHER, H. D., & WOODS, J. A. (2018) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001495 · Cited by 820
The frailty phenotype and the frailty index: different instruments for different purposes
Cesari, M., Gambassi, G., Abellan van Kan, G., & Vellas, B. (2014) · Age and Ageing · doi:10.1093/ageing/aft160 · Cited by 817
Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors
Fiuza-Luces, C., Santos-Lozano, A., Joyner, M., Carrera-Bastos, P., Picazo, O., Zugaza, J. L., Izquierdo, M., Ruilope, L. M., & Lucia, A. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0065-1 · Cited by 803
Inflammation and sarcopenia: A systematic review and meta-analysis
Bano, G., Trevisan, C., Carraro, S., Solmi, M., Luchini, C., Stubbs, B., Manzato, E., Sergi, G., & Veronese, N. (2017) · Maturitas · doi:10.1016/j.maturitas.2016.11.006 · Cited by 801 · cited 1×
“Although these mechanisms have not been confirmed in humans yet, the relevance of systemic inflammation for the pathophysiology of sarcopenia has been demonstrated by many investigations [28].”
BackgroundGut bacteria that prevent growth impairments transmitted by microbiota from malnourished children
Blanton, L. V., Charbonneau, M. R., Salih, T., Barratt, M. J., Venkatesh, S., Ilkaveya, O., Subramanian, S., Manary, M. J., Trehan, I., Jorgensen, J. M., et al. (2016) · Science · doi:10.1126/science.aad3311 · Cited by 735
Barton, W., Penney, N. C., Cronin, O., Garcia-Perez, I., Molloy, M. G., Holmes, E., Shanahan, F., Cotter, P. D., & O'Sullivan, O. (2018) · Gut · doi:10.1136/gutjnl-2016-313627 · Cited by 647
Nutritional determinants of frailty in older adults: A systematic review
Lorenzo-López, L., Maseda, A., de Labra, C., Regueiro-Folgueira, L., Rodríguez-Villamil, J. L., & Millán-Calenti, J. C. (2017) · BMC Geriatrics · doi:10.1186/s12877-017-0496-2 · Cited by 600
Microbiome interactions shape host fitness
Gould, A. L., Zhang, V., Lamberti, L., Jones, E. W., Obadia, B., Korasidis, N., Gavryushkin, A., Carlson, J. M., Beerenwinkel, N., & Ludington, W. B. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809349115 · Cited by 579
Frailty and sarcopenia: The potential role of an aged immune system
Wilson, D., Jackson, T., Sapey, E., & Lord, J. M. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.01.006 · Cited by 573 · cited 1×
“The age-related mechanisms promoting the onset of sarcopenia and physical frailty include inflammation, immunosenescence, anabolic resistance and increased oxidative stress [9,10].”
BackgroundPrebiotic inulin-type fructans induce specific changes in the human gut microbiota
Vandeputte, D., Falony, G., Vieira-Silva, S., Wang, J., Sailer, M., Theis, S., Verbeke, K., & Raes, J. (2017) · Gut · doi:10.1136/gutjnl-2016-313271 · Cited by 554
Beaudart, C., Rolland, Y., Cruz-Jentoft, A. J., Bauer, J. M., Sieber, C., Cooper, C., Al-Daghri, N., Araujo de Carvalho, I., Bautmans, I., Bernabei, R., et al. (2019) · Calcified Tissue International · doi:10.1007/s00223-019-00545-w · Cited by 528
Mailing, L. J., Allen, J. M., Buford, T. W., Fields, C. J., & Woods, J. A. (2019) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000183 · Cited by 521
Does nutrition play a role in the prevention and management of sarcopenia?
Robinson, S. M., Reginster, J. Y., Rizzoli, R., Shaw, S. C., Kanis, J. A., Bautmans, I., Bischoff-Ferrari, H., Bruyère, O., Cesari, M., Dawson-Hughes, B., et al. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2017.08.016 · Cited by 491
Nutrition, frailty, and sarcopenia
Cruz-Jentoft, A. J., Kiesswetter, E., Drey, M., & Sieber, C. C. (2017) · Aging Clinical and Experimental Research · doi:10.1007/s40520-016-0709-0 · Cited by 488 · cited 2×
“This condition frequently overlaps with physical frailty [3], representing the reduction of the capacity to maintain fitness, physical performance and sense of well-being over time and particularly after stressors such as acute illnesses [4].”
BackgroundMicrobiota-gut-brain axis: Modulator of host metabolism and appetite
van de Wouw, M., Schellekens, H., Dinan, T. G., & Cryan, J. F. (2017) · The Journal of Nutrition · doi:10.3945/jn.116.240481 · Cited by 461
Signatures of early frailty in the gut microbiota
Jackson, M. A., Jeffery, I. B., Beaumont, M., Bell, J. T., Clark, A. G., Ley, R. E., O’Toole, P. W., Spector, T. D., & Steves, C. J. (2016) · Genome Medicine · doi:10.1186/s13073-016-0262-7 · Cited by 436
The gut microbiota and healthy aging: A mini-review
Kim, S., & Jazwinski, S. M. (2018) · Gerontology · doi:10.1159/000490615 · Cited by 427
Gait Speed Predicts Incident Disability: A Pooled Analysis
Perera, S., Patel, K. V., Rosano, C., Rubin, S. M., Satterfield, S., Harris, T., Ensrud, K., Orwoll, E., Lee, C. G., Chandler, J. M., et al. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv126 · Cited by 425
Role of the gut microbiota in host appetite control: bacterial growth to animal feeding behaviour
Fetissov, S. O. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.150 · Cited by 403
Ticinesi, A., Lauretani, F., Milani, C., Nouvenne, A., Tana, C., Del Rio, D., Maggio, M., Ventura, M., & Meschi, T. (2017) · Nutrients · doi:10.3390/nu9121303 · Cited by 401 · cited 5×
“Additional possible mechanisms include microbiota-related modifications in bioavailability of nutrients and production of mediators exerting favorable metabolic activity on the host, such as short-chain fatty acids (SCFAs) [22], or toxins exerting negative effects, such as indoxyl sulfate [29].”
BackgroundResultInfluentialSelf-citationUnraveling gut microbiota in Parkinson's disease and atypical parkinsonism
Barichella, M., Severgnini, M., Cilia, R., Cassani, E., Bolliri, C., Caronni, S., Ferri, V., Cancello, R., Ceccarani, C., Faierman, S., et al. (2019) · Movement Disorders · doi:10.1002/mds.27581 · Cited by 393
Grosicki, G. J., Fielding, R. A., & Lustgarten, M. S. (2018) · Calcified Tissue International · doi:10.1007/s00223-017-0345-5 · Cited by 388 · cited 2×
“changes may play a relevant pathophysiological role in determining a reduction of muscle mass, as hypothesized by some authors [21,22].”
BackgroundResultClegg, A., Rogers, L., & Young, J. (2015) · Age and Ageing · doi:10.1093/ageing/afu157 · Cited by 380 · cited 1×
“In fact, frail older patients frequently experience a decline in muscle strength, gait speed and endurance capacity [5,6], ultimately leading to the loss of independence in daily activities, increased risk of falls, fractures, hospital admissions, and death [7].”
BackgroundGlobal variation in grip strength: a systematic review and meta-analysis of normative data
Dodds, R. M., Syddall, H. E., Cooper, R., Kuh, D., Cooper, C., & Sayer, A. A. (2016) · Age and Ageing · doi:10.1093/ageing/afv192 · Cited by 372
Rios-Covian, D., Gueimonde, M., Duncan, S. H., Flint, H. J., & de los Reyes-Gavilan, C. G. (2015) · FEMS Microbiology Letters · doi:10.1093/femsle/fnv176 · Cited by 371
Biagi, E., Nylund, L., Candela, M., Ostan, R., Bucci, L., Pini, E., Nikkïla, J., Monti, D., Satokari, R., Franceschi, C., et al. (2010) · PLoS ONE · doi:10.1371/annotation/df45912f-d15c-44ab-8312-e7ec0607604d · Cited by 345
Walsh, M. E., Bhattacharya, A., Sataranatarajan, K., Qaisar, R., Sloane, L., Rahman, M. M., Kinter, M., & Van Remmen, H. (2015) · Aging Cell · doi:10.1111/acel.12387 · Cited by 334
Intestinal microbiota associated with differential feed conversion efficiency in chickens
Stanley, D., Denman, S. E., Hughes, R. J., Geier, M. S., Crowley, T. M., Chen, H., Haring, V. R., & Moore, R. J. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3847-5 · Cited by 312
A gut microbial factor modulates locomotor behaviour in Drosophila
Schretter, C. E., Vielmetter, J., Bartos, I., Marka, Z., Marka, S., Argade, S., & Mazmanian, S. K. (2018) · Nature · doi:10.1038/s41586-018-0634-9 · Cited by 289
Sarcopenia as the biological substrate of physical frailty
Landi, F., Calvani, R., Cesari, M., Tosato, M., Martone, A. M., Bernabei, R., Onder, G., & Marzetti, E. (2015) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2015.04.005 · Cited by 288 · cited 1×
“Although sarcopenia and physical frailty remain two distinct conditions with different diagnostic criteria, they share a common pathophysiological background and, from the patient’s perspective, are associated with similar negative outcomes [3,8].”
BackgroundKim, D. H., Glynn, R. J., Avorn, J., Lipsitz, L. A., Rockwood, K., Pawar, A., & Schneeweiss, S. (2019) · The Journals of Gerontology: Series A · doi:10.1093/gerona/gly197 · Cited by 285
Ilich, J. Z., Kelly, O. J., Inglis, J. E., Panton, L. B., Duque, G., & Ormsbee, M. J. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.02.007 · Cited by 282 · cited 2×
“One of the main features of this syndrome is the presence of adipose tissue and adipose cells within the muscle structure, the so-called “myosteatosis” [17].”
Backgroundvan Dronkelaar, C., van Velzen, A., Abdelrazek, M., van der Steen, A., Weijs, P. J. M., & Tieland, M. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.05.026 · Cited by 279
Bindels, L. B., Beck, R., Schakman, O., Martin, J. C., De Backer, F., Sohet, F. M., Dewulf, E. M., Pachikian, B. D., Neyrinck, A. M., Thissen, J.-P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037971 · Cited by 278
Munukka, E., Rintala, A., Toivonen, R., Nylund, M., Yang, B., Takanen, A., Hänninen, A., Vuopio, J., Huovinen, P., Jalkanen, S., et al. (2017) · The ISME Journal · doi:10.1038/ismej.2017.24 · Cited by 278
Oxidative stress and frailty: A systematic review and synthesis of the best evidence
Soysal, P., Isik, A. T., Carvalho, A. F., Fernandes, B. S., Solmi, M., Schofield, P., Veronese, N., & Stubbs, B. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.01.006 · Cited by 252 · cited 1×
“The age-related mechanisms promoting the onset of sarcopenia and physical frailty include inflammation, immunosenescence, anabolic resistance and increased oxidative stress [9,10].”
BackgroundBeaumont, M., Portune, K. J., Steuer, N., Lan, A., Cerrudo, V., Audebert, M., Dumont, F., Mancano, G., Khodorova, N., Andriamihaja, M., et al. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.158816 · Cited by 250
The intestinal microbiome, probiotics and prebiotics in neurogastroenterology
Saulnier, D. M., Ringel, Y., Heyman, M. B., Foster, J. A., Bercik, P., Shulman, R. J., Versalovic, J., Verdu, E. F., Dinan, T. G., Hecht, G., et al. (2013) · Gut Microbes · doi:10.4161/gmic.22973 · Cited by 248
Cerdá, B., Pérez, M., Pérez-Santiago, J. D., Tornero-Aguilera, J. F., González-Soltero, R., & Larrosa, M. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00051 · Cited by 247
Sovran, B., Hugenholtz, F., Elderman, M., Van Beek, A. A., Graversen, K., Huijskes, M., Boekschoten, M. V., Savelkoul, H. F. J., De Vos, P., Dekker, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-35228-3 · Cited by 234 · cited 1×
“In this possible gut-muscle axis, age-associated dysfunction of the gut mucosal barrier function may play a central role [23], favoring the entry of microbial products or microbes themselves into systemic circulation [24], and contributing to activate the inflammatory response and induce immune system dysregulation [2…”
BackgroundBuch, A., Carmeli, E., Boker, L. K., Marcus, Y., Shefer, G., Kis, O., Berner, Y., & Stern, N. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.01.008 · Cited by 227 · cited 1×
“In fact, frail older patients frequently experience a decline in muscle strength, gait speed and endurance capacity [5,6], ultimately leading to the loss of independence in daily activities, increased risk of falls, fractures, hospital admissions, and death [7].”
BackgroundMalnutrition, fatigue, frailty, vulnerability, sarcopenia and cachexia: overlap of clinical features
Jeejeebhoy, K. N. (2012) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328352694f · Cited by 226
Effect of a Prebiotic Formulation on Frailty Syndrome: A Randomized, Double-Blind Clinical Trial
Buigues, C., Fernández-Garrido, J., Pruimboom, L., Hoogland, A., Navarro-Martínez, R., Martínez-Martínez, M., Verdejo, Y., Mascarós, M., Peris, C., & Cauli, O. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060932 · Cited by 222
Biological aging and the human gut microbiota
Maffei, V. J., Kim, S., Blanchard, E., Luo, M., Jazwinski, S. M., Taylor, C. M., & Welsh, D. A. (2017) · The Journals of Gerontology Series A · doi:10.1093/gerona/glx042 · Cited by 219
Milani, C., Ticinesi, A., Gerritsen, J., Nouvenne, A., Lugli, G. A., Mancabelli, L., Turroni, F., Duranti, S., Mangifesta, M., Viappiani, A., et al. (2016) · Scientific Reports · doi:10.1038/srep25945 · Cited by 217
Self-citationGut microbiota, cognitive frailty and dementia in older individuals: A systematic review
Ticinesi, A., Tana, C., Nouvenne, A., Prati, B., Lauretani, F., & Meschi, T. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s139163 · Cited by 215
Self-citationGut bacteria are critical for optimal muscle function: a potential link with glucose homeostasis
Nay, K., Jollet, M., Goustard, B., Baati, N., Vernus, B., Pontones, M., Lefeuvre-Orfila, L., Bendavid, C., Rué, O., Mariadassou, M., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00521.2018 · Cited by 215
Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients
Ticinesi, A., Milani, C., Lauretani, F., Nouvenne, A., Mancabelli, L., Lugli, G. A., Turroni, F., Duranti, S., Mangifesta, M., Viappiani, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10734-y · Cited by 211
Self-citationShort-Physical Performance Battery (SPPB) score is associated with falls in older outpatients
Lauretani, F., Ticinesi, A., Gionti, L., Prati, B., Nouvenne, A., Tana, C., Meschi, T., & Maggio, M. (2019) · Aging Clinical and Experimental Research · doi:10.1007/s40520-018-1082-y · Cited by 211
Self-citationAge-dependent changes in GI physiology and microbiota: time to reconsider?
An, R., Wilms, E., Masclee, A. A. M., Smidt, H., Zoetendal, E. G., & Jonkers, D. (2018) · Gut · doi:10.1136/gutjnl-2017-315542 · Cited by 209
Towards a multidisciplinary approach to understand and manage obesity and related diseases
Bischoff, S. C., Boirie, Y., Cederholm, T., Chourdakis, M., Cuerda, C., Delzenne, N. M., Deutz, N. E., Fouque, D., Genton, L., Gil, C., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.11.007 · Cited by 206
Bjørkhaug, S. T., Aanes, H., Neupane, S. P., Bramness, J. G., Malvik, S., Henriksen, C., Skar, V., Medhus, A. W., & Valeur, J. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1580097 · Cited by 205
Indoles from commensal bacteria extend healthspan
Sonowal, R., Swimm, A., Sahoo, A., Luo, L., Matsunaga, Y., Wu, Z., Bhingarde, J. A., Ejzak, E. A., Ranawade, A., Qadota, H., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706464114 · Cited by 197
Intermuscular adipose tissue directly modulates skeletal muscle insulin sensitivity in humans
Sachs, S., Zarini, S., Kahn, D. E., Harrison, K. A., Perreault, L., Phang, T., Newsom, S. A., Strauss, A., Kerege, A., Schoen, J. A., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00243.2018 · Cited by 192
Enoki, Y., Watanabe, H., Arake, R., Sugimoto, R., Imafuku, T., Tominaga, Y., Ishima, Y., Kotani, S., Nakajima, M., Tanaka, M., et al. (2016) · Scientific Reports · doi:10.1038/srep32084 · Cited by 188 · cited 2×
“Namely, the circulating levels of microbiota-derived indoxyl sulfate are positively associated with the expression of myostatin and atrogin-1 [29], representing two of the main negative regulators of skeletal muscle mass [30].”
BackgroundHost genotype and gut microbiome modulate insulin secretion and diet-induced metabolic phenotypes
Kreznar, J. H., Keller, M. P., Traeger, L. L., Rabaglia, M. E., Schueler, K. L., Stapleton, D. S., Zhao, W., Vivas, E. I., Yandell, B. S., Broman, A. T., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.062 · Cited by 177
Microbiota-mitochondria inter-talk: Consequence for microbiota-host interaction
Saint-Georges-Chaumet, Y., & Edeas, M. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftv096 · Cited by 176
Morita, E., Yokoyama, H., Imai, D., Takeda, R., Ota, A., Kawai, E., Hisada, T., Emoto, M., Suzuki, Y., & Okazaki, K. (2019) · Nutrients · doi:10.3390/nu11040868 · Cited by 169
The gut microbiota of centenarians: Signatures of longevity in the gut microbiota profile
Biagi, E., Rampelli, S., Turroni, S., Quercia, S., Candela, M., & Brigidi, P. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.12.013 · Cited by 166
Instrumental and Non-Instrumental Evaluation of 4-Meter Walking Speed in Older Individuals
Maggio, M., Ceda, G. P., Ticinesi, A., De Vita, F., Gelmini, G., Costantino, C., Meschi, T., Kressig, R. W., Cesari, M., Fabi, M., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153583 · Cited by 160
Self-citationMoreno-Pérez, D., Bressa, C., Bailén, M., Hamed-Bousdar, S., Naclerio, F., Carmona, M., Pérez, M., González-Soltero, R., Montalvo-Lominchar, M., Carabaña, C., et al. (2018) · Nutrients · doi:10.3390/nu10030337 · Cited by 158
Feeding the microbiota: Transducer of nutrient signals for the host
Shanahan, F., van Sinderen, D., O’Toole, P. W., & Stanton, C. (2017) · Gut · doi:10.1136/gutjnl-2017-313872 · Cited by 157
Reinders, I., Murphy, R. A., Brouwer, I. A., Visser, M., Launer, L., Siggeirsdottir, K., Eiriksdottir, G., Gudnason, V., Jonsson, P. V., Lang, T. F., et al. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv153 · Cited by 155
Anorexia of ageing: a key component in the pathogenesis of both sarcopenia and cachexia
Morley, J. E. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12192 · Cited by 149
Beneficial bacteria inhibit cachexia
Varian, B. J., Goureshetti, S., Poutahidis, T., Lakritz, J. R., Levkovich, T., Kwok, C., Teliousis, K., Ibrahim, Y. M., Mirabal, S., & Erdman, S. E. (2016) · Oncotarget · doi:10.18632/oncotarget.7730 · Cited by 146
Ticinesi, A., Lauretani, F., Tana, C., Nouvenne, A., Ridolo, E., & Nleschi, T. (2026) · Exercise Immunology Review · doi:10.22029/eir.2019.1723 · Cited by 146
Self-citationMiljkovic, I., Kuipers, A. L., Cauley, J. A., Prasad, T., Lee, C. G., Ensrud, K. E., Cawthon, P. M., Hoffman, A. R., Dam, T.-T., Gordon, C. L., et al. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv027 · Cited by 144 · cited 1×
“Myosteatosis represents the result of increased systemic anabolic resistance and is independently associated with increased mortality risk according to population-based studies [19,20].”
BackgroundAzpiroz, F., Dubray, C., Bernalier‐Donadille, A., Cardot, J. ‐., Accarino, A., Serra, J., Wagner, A., Respondek, F., & Dapoigny, M. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.12911 · Cited by 141
Mao, B., Gu, J., Li, D., Cui, S., Zhao, J., Zhang, H., & Chen, W. (2018) · Nutrients · doi:10.3390/nu10081105 · Cited by 140
Yan, H., Diao, H., Xiao, Y., Li, W., Yu, B., He, J., Yu, J., Zheng, P., Mao, X., Luo, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep31786 · Cited by 138
Dietary Protein and Muscle in Aging People: The Potential Role of the Gut Microbiome
Ni Lochlainn, M., Bowyer, R. C. E., & Steves, C. J. (2018) · Nutrients · doi:10.3390/nu10070929 · Cited by 138
Dietary Protein and Muscle in Aging People: The Potential Role of the Gut Microbiome
Ni Lochlainn, M., Bowyer, R. C. E., & Steves, C. J. (2018) · doi:10.20944/preprints201806.0152.v1 · Cited by 138
Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass
Sakuma, K., & Yamaguchi, A. (2012) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-011-0052-4 · Cited by 137 · cited 1×
“Namely, the circulating levels of microbiota-derived indoxyl sulfate are positively associated with the expression of myostatin and atrogin-1 [29], representing two of the main negative regulators of skeletal muscle mass [30].”
BackgroundLozano-Montoya, I., Correa-Pérez, A., Abraha, I., Soiza, R. L., Cherubini, A., O'Mahony, D., & Cruz-Jentoft, A. J. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s132496 · Cited by 130 · cited 2×
“Thus, exercise and nutritional supplementation are considered the current pillars for the treatment and prevention of physical frailty and sarcopenia [14,15].”
BackgroundSiddharth, J., Chakrabarti, A., Pannérec, A., Karaz, S., Morin-Rivron, D., Masoodi, M., Feige, J. N., & Parkinson, S. J. (2017) · Aging · doi:10.18632/aging.101262 · Cited by 127
Osteosarcopenic Obesity: Current Knowledge, Revised Identification Criteria and Treatment Principles
Kelly, O. J., Gilman, J. C., Boschiero, D., & Ilich, J. Z. (2019) · Nutrients · doi:10.3390/nu11040747 · Cited by 126 · cited 1×
“In some patients, sarcopenia and physical frailty may coexist with reduced bone mineral density (BMD) and excess adipose tissue, in a clinical picture that has been recently defined as osteosarcopenic obesity [17,18].”
BackgroundBlachier, F., Beaumont, M., Portune, K. J., Steuer, N., Lan, A., Audebert, M., Khodorova, N., Andriamihaja, M., Airinei, G., Benamouzig, R., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.09.016 · Cited by 124
Microbiome-health interactions in older people
O’Toole, P. W., & Jeffery, I. B. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2673-z · Cited by 117
Update on mitochondria and muscle aging: All wrong roads lead to sarcopenia
Picca, A., Calvani, R., Bossola, M., Allocca, E., Menghi, A., Pesce, V., Lezza, A. M. S., Bernabei, R., Landi, F., & Marzetti, E. (2018) · Biological Chemistry · doi:10.1515/hsz-2017-0331 · Cited by 116
Nutrition and exercise in sarcopenia
Anton, S. D., Hida, A., Mankowski, R., Layne, A., Solberg, L. M., Mainous, A. G., & Buford, T. (2018) · Current Protein & Peptide Science · doi:10.2174/1389203717666161227144349 · Cited by 113 · cited 2×
“Thus, exercise and nutritional supplementation are considered the current pillars for the treatment and prevention of physical frailty and sarcopenia [14,15].”
BackgroundReduced mitochondrial lipid oxidation leads to fat accumulation in myosteatosis
Gumucio, J. P., Qasawa, A. H., Ferrara, P. J., Malik, A. N., Funai, K., McDonagh, B., & Mendias, C. L. (2019) · The FASEB Journal · doi:10.1096/fj.201802457rr · Cited by 107
Liu, X., Blouin, J.-M., Santacruz, A., Lan, A., Andriamihaja, M., Wilkanowicz, S., Benetti, P.-H., Tomé, D., Sanz, Y., Blachier, F., et al. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00400.2013 · Cited by 103
Tuikhar, N., Keisam, S., Labala, R. K., Imrat, Ramakrishnan, P., Arunkumar, M. C., Ahmed, G., Biagi, E., & Jeyaram, K. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.02.001 · Cited by 103
Ticinesi, A., Meschi, T., Lauretani, F., Felis, G., Franchi, F., Pedrolli, C., Barichella, M., Benati, G., Di Nuzzo, S., Ceda, G., et al. (2016) · Nutrients · doi:10.3390/nu8040186 · Cited by 101
Self-citationVeronese, N., Stubbs, B., Trevisan, C., Bolzetta, F., De Rui, M., Solmi, M., Sartori, L., Musacchio, E., Zambon, S., Perissinotto, E., et al. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.05.008 · Cited by 99
Haran, J. P., Bucci, V., Dutta, P., Ward, D., & McCormick, B. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000640 · Cited by 97
Of microbes and minds: A narrative review on the second brain aging
Calvani, R., Picca, A., Lo Monaco, M. R., Landi, F., Bernabei, R., & Marzetti, E. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00053 · Cited by 92
Gut microbiome catabolites as novel modulators of muscle cell glucose metabolism
Houghton, M. J., Kerimi, A., Mouly, V., Tumova, S., & Williamson, G. (2019) · The FASEB Journal · doi:10.1096/fj.201801209r · Cited by 92
A comparison of objective physical performance tests and future mortality in the elderly people
Veronese, N., Stubbs, B., Fontana, L., Trevisan, C., Bolzetta, F., Rui, M. D., Sartori, L., Musacchio, E., Zambon, S., Maggi, S., et al. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw139 · Cited by 90
“Brain-muscle loop” in the fragility of older persons: from pathophysiology to new organizing models
Lauretani, F., Meschi, T., Ticinesi, A., & Maggio, M. G. (2017) · Aging Clinical and Experimental Research · doi:10.1007/s40520-017-0729-4 · Cited by 90
Self-citationResveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure
Sung, M. M., Byrne, N. J., Robertson, I. M., Kim, T. T., Samokhvalov, V., Levasseur, J., Soltys, C.-L., Fung, D., Tyreman, N., Denou, E., et al. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00455.2016 · Cited by 88
Composition of salivary microbiota in elderly subjects
Ogawa, T., Hirose, Y., Honda-Ogawa, M., Sugimoto, M., Sasaki, S., Kibi, M., Kawabata, S., Ikebe, K., & Maeda, Y. (2018) · Scientific Reports · doi:10.1038/s41598-017-18677-0 · Cited by 83
An investigation into physical frailty as a link between the gut microbiome and cognitive health
Verdi, S., Jackson, M. A., Beaumont, M., Bowyer, R. C. E., Bell, J. T., Spector, T. D., & Steves, C. J. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00398 · Cited by 82
Protective Effects of Ghrelin on Fasting-Induced Muscle Atrophy in Aging Mice
Wu, C.-S., Wei, Q., Wang, H., Kim, D. M., Balderas, M., Wu, G., Lawler, J., Safe, S., Guo, S., Devaraj, S., et al. (2020) · The Journals of Gerontology: Series A · doi:10.1093/gerona/gly256 · Cited by 81
The intestinal microbiome and its relevance for functionality in older persons
Ticinesi, A., Tana, C., & Nouvenne, A. (2019) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000521 · Cited by 80
Self-citationRomán, E., Nieto, J. C., Gely, C., Vidal, S., Pozuelo, M., Poca, M., Juárez, C., Guarner, C., Manichanh, C., & Soriano, G. (2019) · Hepatology Communications · doi:10.1002/hep4.1325 · Cited by 80
Sarcopenia: the new definitions
Cederholm, T., & Morley, J. E. (2015) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000119 · Cited by 78
Effect of Lactobacillus Plantarum TWK10 on Improving Endurance Performance in Humans
Huang, W.-C. (2018) · The Chinese Journal of Physiology · doi:10.4077/cjp.2018.bah587 · Cited by 78
The human microbiome in health and disease: hype or hope
Falony, G., Vandeputte, D., Caenepeel, C., Vieira‐Silva, S., Daryoush, T., Vermeire, S., & Raes, J. (2019) · Acta Clinica Belgica · doi:10.1080/17843286.2019.1583782 · Cited by 78
Composition and richness of the serum microbiome differ by age and link to systemic inflammation
Buford, T. W., Carter, C. S., VanDerPol, W. J., Chen, D., Lefkowitz, E. J., Eipers, P., Morrow, C. D., & Bamman, M. M. (2018) · GeroScience · doi:10.1007/s11357-018-0026-y · Cited by 77 · cited 1×
“In this possible gut-muscle axis, age-associated dysfunction of the gut mucosal barrier function may play a central role [23], favoring the entry of microbial products or microbes themselves into systemic circulation [24], and contributing to activate the inflammatory response and induce immune system dysregulation [2…”
BackgroundYang, Y., Shi, Y., Wiklund, P., Tan, X., Wu, N., Zhang, X., Tikkanen, O., Zhang, C., Munukka, E., & Cheng, S. (2017) · Nutrients · doi:10.3390/nu9080792 · Cited by 72
Nutritional influence on bone: role of gut microbiota
Rizzoli, R. (2019) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01131-8 · Cited by 72
Townsend, J. R., Bender, D., Vantrease, W. C., Sapp, P. A., Toy, A. M., Woods, C. A., & Johnson, K. D. (2018) · Sports · doi:10.3390/sports6030070 · Cited by 69
Poggiogalle, E., Lubrano, C., Gnessi, L., Mariani, S., Di Martino, M., Catalano, C., Lenzi, A., & Donini, L. M. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.01.028 · Cited by 69
Prospective views for whey protein and/or resistance training against age-related sarcopenia
Liao, Y., Peng, Z., Chen, L., Zhang, Y., Cheng, Q., Nüssler, A. K., Bao, W., Liu, L., & Yang, W. (2019) · Aging and Disease · doi:10.14336/ad.2018.0325 · Cited by 68
Temporal microbiota changes of high-protein diet intake in a rat model
Mu, C., Yang, Y., Luo, Z., & Zhu, W. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.06.003 · Cited by 67
Gait Speed and Mobility Disability: Revisiting Meaningful Levels in Diverse Clinical Populations
Miller, M. E., Magaziner, J., Marsh, A. P., Fielding, R. A., Gill, T. M., King, A. C., Kritchevsky, S. B., Manini, T. M., McDermott, M. M., Neiberg, R. H., et al. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15331 · Cited by 63
Can a Prebiotic Formulation Reduce Frailty Levels in Older People?
Theou, O., Jayanama, K., Fernández-Garrido, J., Buigues, C., Pruimboom, L., Hoogland, A. J., Navarro-Martínez, R., Rockwood, K., & Cauli, O. (2019) · The Journal of Frailty & Aging · doi:10.14283/jfa.2018.39 · Cited by 60
Effect of a long-term high-protein diet on survival, obesity development, and gut microbiota in mice
Kiilerich, P., Myrmel, L. S., Fjære, E., Hao, Q., Hugenholtz, F., Sonne, S. B., Derrien, M., Pedersen, L. M., Petersen, R. K., Mortensen, A., et al. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00363.2015 · Cited by 58
Henique, C., Mansouri, A., Vavrova, E., Lenoir, V., Ferry, A., Esnous, C., Ramond, E., Girard, J., Bouillaud, F., Prip‐Buus, C., et al. (2015) · The FASEB Journal · doi:10.1096/fj.14-257717 · Cited by 56
Toxoplasma gondii infection triggers chronic cachexia and sustained commensal dysbiosis in mice
Hatter, J. A., Kouche, Y. M., Melchor, S. J., Ng, K., Bouley, D. M., Boothroyd, J. C., & Ewald, S. E. (2018) · doi:10.1101/247866 · Cited by 56
Toxoplasma gondii infection triggers chronic cachexia and sustained commensal dysbiosis in mice
Hatter, J. A., Kouche, Y. M., Melchor, S. J., Ng, K., Bouley, D. M., Boothroyd, J. C., & Ewald, S. E. (2018) · PLOS ONE · doi:10.1371/journal.pone.0204895 · Cited by 56
Physical exercise, nutrition and hormones: three pillars to fight sarcopenia
Sgrò, P., Sansone, M., Sansone, A., Sabatini, S., Borrione, P., Romanelli, F., & Luigi, L. D. (2018) · The Aging Male · doi:10.1080/13685538.2018.1439004 · Cited by 55 · cited 1×
“Anabolic hormones could also have a possible therapeutical role in selected situations, where hormonal deficiency can be demonstrated by clinical examinations [16].”
BackgroundAbe, T., Kitamura, A., Taniguchi, Y., Amano, H., Seino, S., Yokoyama, Y., Nishi, M., Narita, M., Ikeuchi, T., Fujiwara, Y., et al. (2019) · Maturitas · doi:10.1016/j.maturitas.2019.02.002 · Cited by 50
Dietary ursolic acid improves health span and life span in male Drosophila melanogaster
Staats, S., Wagner, A. E., Lüersen, K., Künstner, A., Meyer, T., Kahns, A. K., Derer, S., Graspeuntner, S., Rupp, J., Busch, H., et al. (2019) · BioFactors · doi:10.1002/biof.1467 · Cited by 48
Gut microbiota in common elderly diseases affecting activities of daily living
Shimizu, Y. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i42.4750 · Cited by 40
Gut Microbiota, Probiotics, and Sport: From Clinical Evidence to Agonistic Performance
Pane, M., Amoruso, A., Deidda, F., Graziano, T., Allesina, S., & Mogna, L. (2018) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001058 · Cited by 32
Ticinesi, A., Nouvenne, A., Tana, C., Prati, B., Cerundolo, N., Miraglia, C., Angelis, G. L. D., Mario, F. D., & Meschi, T. (2018) · PubMed Central · doi:10.23750/abm.v89i9-s.7906 · Cited by 26
Self-citationPhysical status and frailty index in nursing home residents: Results from the INCUR study
Tabue-Teguo, M., Dartigues, J.-F., Simo, N., Kuate-Tegueu, C., Vellas, B., & Cesari, M. (2018) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2017.10.005 · Cited by 25
Hsu, T.-H., Chiu, C.-C., Wang, Y.-C., Chen, T.-H., Chen, Y.-H., Lee, Y.-P., Hung, S.-W., Wu, C.-P., & Chuang, H.-L. (2018) · Nutrients · doi:10.3390/nu10111740 · Cited by 20
A Comparison of Objective Physical Performance Tests and Future Mortality in the Elderly People
Kiselev, J. (2017) · physioscience · doi:10.1055/s-0035-1567161 · Cited by 13
Human gut microbiome: the hypothesis of a gut-muscle axis in the elderly
Ticinesi, A., Tana, C., Nouvenne, A., & Meschi, T. (2018) · Deutsche Zeitschrift für Sportmedizin · doi:10.5960/dzsm.2018.355 · Cited by 4
Self-citation
Cited by
Gut microbiota and dysbiosis in Alzheimer's disease: Implications for pathogenesis and treatment
Liu, S., Gao, J., Zhu, M., Liu, K., & Zhang, H.-L. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02073-3 · Cited by 516
“Gut dysbiosis may be associated with pathologies such as asthma [31], cardiovascular disease [32], type 2 diabetes mellitus (T2DM) [33], renal failure [34], and sarcopenia [35].”
BackgroundEl Assar, M., Álvarez-Bustos, A., Sosa, P., Angulo, J., & Rodríguez-Mañas, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158713 · Cited by 371
“Myokine alteration Apelin increases mitocondriogenesis and reduces inflammation Myostatin inhibits muscle synthesis and promotes muscle catabolism and is inhibited by follistatin Adiponectin increases mitochondrial function and augments oxidative fibers Irisin improves mitochondrial function decreases ROS production a…”
BackgroundUnderstanding the gut microbiota and sarcopenia: a systematic review
Liu, C., Cheung, W., Li, J., Chow, S. K., Yu, J., Wong, S. H., Ip, M., Sung, J. J. Y., & Wong, R. M. Y. (2021) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12784 · Cited by 363
“More importantly, advanced age not only affects the muscle but also causes gut microbiome dysbiosis,(27) with altered microbial diversity and predominant bacteria, and lower beneficial bacterial metabolites.(28,29) Gut microbiota-derived”
BackgroundLing, Z., Liu, X., Cheng, Y., Yan, X., & Wu, S. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1867054 · Cited by 352
“The gut-muscle axis refers to the roles for the gut microbiota on the maintenance of whole body lean mass, skeletal muscle mass, and physical function (De Sire et al. 2018; Grosicki, Fielding, and Lustgarten 2018; Ni Lochlainn, Bowyer, and Steves 2018; Picca et al. 2018; Ticinesi et al. 2019).”
BackgroundBilski, J., Pierzchalski, P., Szczepanik, M., Bonior, J., & Zoladz, J. (2022) · Cells · doi:10.3390/cells11010160 · Cited by 251
“This may suggest that, in older people, the dysbiotic gut microbiota could influence the onset of sarcopenia and physical frailty also by promotion of malnutrition [123].”
BackgroundInfluential
Metadata
- Authors
- Ticinesi, A., Nouvenne, A., Cerundolo, N., Catania, P., Prati, B., Tana, C., & Meschi, T.
- Affiliations
- University of Parma (IT)
- Ospedale di Parma (IT)
- Corresponding author
- Ticinesi, Andrea
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-07-17
- Volume
- 11
- Issue
- 7
- Pages
- 1633
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6683074
- OpenAlex
- W2961066137
- Semantic Scholar
- fecf6f6df4b36ccd42a489508be21efdeb7072a1
- Cited by
- 418
- References
- 144
- Citations by year
- 2026: 60 · 2025: 61 · 2024: 88 · 2023: 73 · 2022: 49 · 2021: 44 · 2020: 36 · 2019: 6
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Keywords
- gut microbiota, aging, sarcopenia, physical frailty, muscle mass, muscle function, gut-muscle axis, microbiome diversity, butyrate, probiotics, Faecalibacterium, Bifidobacterium, grip strength, walking speed, parkinsonism, physical performance
- MeSH terms
- Gastrointestinal Microbiome, Frailty, Aged, Animals, Humans, Muscle, Skeletal, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
